Diagnostics & Testing

Nucleai provides AI-powered spatial biomarker and diagnostics solutions for biopharma, analyzing cellular interactions in tissue samples to advance drug development in oncology. Their platform uses deep learning for multiplex immunofluorescence analysis, automating normalization of high-plex imaging data to identify biomarkers for ADCs, bispecifics, immunotherapy, NSCLC, and melanoma. It enables precise prediction of treatment responses and scalable validation across cohorts.

Informuta develops precision diagnostics for drug-resistant infections using machine learning and DNA sequencing technology. The company's RESISENSE platform forecasts treatment-emergent antibiotic resistance before it occurs, enabling clinicians to select optimal therapies on a patient-by-patient basis. Informuta's technology helps prevent treatment failures, reduce antibiotic misuse, and strengthen antimicrobial stewardship in hospital settings.

Abcam is a life sciences company established in 1998 that provides highly validated antibodies, assays, proteins, and research reagents to support drug discovery, diagnostics, and basic research. The company serves 750,000 researchers across 130+ countries and offers full-cycle support from antibody identification and development through validation, pre-clinical selection, and commercialization. Abcam specializes in delivering well-characterized proteins and reagents targeting critical biological pathways in cancer, neurological disorders, infectious diseases, and metabolic disorders. Now operating as part of Danaher's Life Sciences segment, Abcam continues to provide expert scientific support and data-driven expertise in antibody discovery and production.

Agilent Technologies provides instruments, software, services, and consumables for analytical laboratories in life sciences, diagnostics, and applied chemical markets. Key offerings include gas and liquid chromatography, mass spectrometry, spectroscopy, automation, bioreagents, and informatics tools supporting pharmaceutical development, clinical diagnostics, and research workflows. The company maintains a global presence with R&D, manufacturing, sales, and support across Europe, Americas, and Asia Pacific.

Alpha Laboratories provides comprehensive diagnostic testing services to healthcare professionals, hospitals, and clinical research organizations in Ontario, Canada, since 1972. Their offerings include clinical chemistry, hematology, urinalysis, anatomical pathology, cytology, immunohematology, and advanced molecular diagnostics for infectious diseases like Chlamydia and gonorrhoeae using real-time PCR. The company is licensed by the Ontario Ministry of Health and accredited by Accreditation Canada Diagnostics.

AltaBioscience provides UKAS-accredited ISO 17025:2017 analytical services for amino acid analysis and protein sequencing, alongside ISO 9001:2015 certification for custom peptide synthesis, DNA oligos, and antibody production. These services support pharmaceutical R&D in protein research, drug development, vaccine production, and GMP sample analysis. With over 50 years of experience, the UK-based laboratory delivers high-quality biochemicals and mass spectrometry testing to global pharma and biotech clients.

Ambry Genetics, a Tempus Company, specializes in clinical genetic testing using advanced genomic technologies like DNA/RNA analysis and next-generation sequencing (NGS) for hereditary cancers, oncology, neurology, and rare diseases. They offer pharma services supporting drug development across therapeutic areas including gene therapy and cardiovascular diseases, with a CLIA/CAP-certified SuperLab for high-volume and customized testing. Their expertise translates research into actionable insights for pharmaceutical partners and clinicians.

Amprion Diagnostics offers the SAAmplify-ɑSYN test, a seed amplification assay that detects misfolded alpha-synuclein in cerebrospinal fluid (CSF) to aid diagnosis of synucleinopathies including Parkinson's disease, Lewy body dementia, multiple system atrophy, and Alzheimer's with Lewy body co-pathology. The test provides autopsy-confirmed accuracy, having analyzed over 20,000 samples, and supports treatment decisions with biological evidence. It has received US FDA Breakthrough Device Designation and is available through partnerships like Mayo Clinic Laboratories.

AnteoTech develops niche diagnostic products and solutions for healthcare, agriculture, and veterinary sciences using patented metal-ion-based technology. They offer ready-to-use kits with AnteoBind™ for surface activation and bioconjugation on microspheres, nanospheres, and planar surfaces. Their R&D is ISO 9001 compliant, supporting in-vitro diagnostics and advanced material solutions.

Aptamer Group develops Optimer synthetic binders, next-generation aptamers for life sciences and pharma applications including biomarker discovery, targeted drug delivery, and therapeutics. Their proprietary platforms enable custom aptamer selection for targets from small molecules to proteins, supporting drug discovery, diagnostics, and gene therapy delivery. Services are offered via fee-for-service models, integrating Optimer technology with proteomic analysis for high-throughput biomarker identification.

Arima Genomics provides Hi-C technology and end-to-end solutions for 3D genomic analysis, enabling discovery of biomarkers and therapies in human health, cancer diagnostics, and epigenetics. Their assays capture long-range chromatin interactions, including compartments, TADs, and loops, with user-friendly workflows compatible with standard NGS protocols and low-input DNA options. Partnerships like with Fox Chase Cancer Center integrate their Aventa tests into clinical protocols for lymphoma and sarcoma.

Gyros Protein Technologies provides automated nanoliter-scale immunoassays via Gyrolab systems for bioprocess analytics, including Protein A kits for residual ligand quantification and biomarker kits for cytokines. They offer peptide synthesizers, reagents, and purification solutions like PurePep EasyClean technology, partnered with Biotage for high-throughput automated peptide purification. These tools support drug discovery, development, and biotherapeutics manufacturing with high sensitivity, throughput, and reduced solvent use.

Aviva Systems Biology offers a broad portfolio of over 20,000 polyclonal and monoclonal antibodies, immunoassay kits, recombinant proteins, and custom protein expression services for proteomics research. Headquartered in San Diego, California, the company supports applications including western blotting, IHC, ELISA, and immunoprecipitation for academic and biopharma researchers. They partner with platforms like Quantum-Si for protein enrichment kits and emphasize high-throughput antibody characterization.

Bio-Techne is a global developer and manufacturer of high-quality reagents, analytical instruments, and precision diagnostics for life sciences and pharma. Its portfolio, organized under R&D Systems, Bio-Techne Spatial, and Bio-Techne Diagnostics brands, supports discovery, translational research, and clinical applications with over 500,000 products. The company operates in 34 locations worldwide, serving academic, biopharma, biotech, and diagnostic labs.

Biodesix provides advanced blood-based diagnostic tests for lung cancer risk assessment and treatment guidance, including Nodify Lung, GeneStrat, and VeriStrat tests. They offer custom development services to biopharmaceutical and life sciences companies for therapeutic clinical trials, diagnostic validation, and commercialization of IVD and LDT tests. Their AI and machine learning capabilities support personalized care and early lung cancer detection.

Biohit is a Finnish biotechnology company established in 1988 that specializes in in vitro diagnostic (IVD) devices and automated analysis systems for gastrointestinal disease diagnosis and prevention. The company offers a comprehensive portfolio including GastroPanel blood tests, rapid diagnostic kits, and automated immunoassay analyzers, with manufacturing capabilities including a 25,000 m² facility in Hefei with 200 automated production lines. Biohit serves global markets across 50+ countries with products addressing early diagnosis of gastric diseases, H. pylori infection, lactose intolerance, and laryngopharyngeal reflux, alongside COVID-19 diagnostic tests.

Logical Biological supplies high-quality human biological materials including serum, plasma, tissues, PBMCs, swabs, and cells to support in vitro diagnostics (IVD) control manufacturing, diagnostics, and therapeutics R&D. The company offers customizable biospecimens, bulk disease state plasma, and engineered materials through partnerships, backed by extensive development and manufacturing capabilities. Headquartered in the UK with a global network of 45 clinical collection sites, it ensures sustainable supply to international customers.

CENTOGENE provides advanced genetic and multiomic testing for rare, neurodegenerative, neurological, oncology, endocrinology, and other diseases, powered by the world's largest genetic testing portfolio covering 19,000 genes and the CENTOGENE Biodatabank. Their solutions include genome-wide CNV analysis via CentoArray, comprehensive NGS panels like CentoNeuro, and global sample logistics with CentoCard. The company aims to cure 100 rare diseases in the next decade, prioritizing neurological and metabolic disorders.

CARB-X is a global non-profit partnership that accelerates the development of antibacterial products to combat drug-resistant bacteria. The organization provides non-dilutive funding, scientific expertise, regulatory guidance, and business support to developers of new antibiotics, preventatives, rapid diagnostics, and related products. CARB-X maintains the world's most scientifically diverse early-stage pipeline, supporting projects from basic research through Phase 1 clinical trials and prototype development.

Cleveland Diagnostics develops novel blood-based diagnostic tests for early cancer detection, focusing on prostate cancer with its IsoPSA test to reduce unnecessary biopsies. The company's IsoClear platform analyzes protein structural differences for higher accuracy and specificity in identifying cancer biomarkers. They offer lab-friendly, affordable tests expanding to additional cancers, supported by partnerships like Quest Diagnostics.

Clinisys is a market-leading provider of single-platform healthcare software solutions for pathology laboratories, including clinical pathology, genomics, and genetics disciplines. Their Clinisys Laboratory Solution (CLS) delivers cloud-based laboratory information systems with end-to-end specimen management, advanced analytics, and pre-configured workflows. The platform supports North American clinical and research laboratories with capabilities including next-generation sequencing workflows, quality control automation, and AI-powered support tools. Clinisys also serves public health, contract research, and food safety testing laboratories with comprehensive LIMS solutions.

Countable Labs offers Countable PCR, a highly sensitive single-molecule PCR platform that achieves 10x better sensitivity and precision than standard PCR, detecting rare variants down to 0.004% VAF. The technology supports 4-color and 10-color multiplexing via the Countable 10 instrument, simplifying workflows for gene therapy, rare event detection, and biopharma screening. They provide assay development services, instruments priced at $150K, and consumables at $16 per sample.

Crown Bioscience is a global contract research organization providing integrated biomarker services, preclinical models, and translational platforms for pharmaceutical and biotechnology companies. The company offers tissue-based analysis, genomics, proteomics, and comprehensive bioinformatics services across in vivo, in vitro, ex vivo, and in silico platforms. Crown operates over 800 organoid models and 2,700 PDX models enhanced by biomarker analysis, supporting drug efficacy assessment and pharmacological profiling from discovery through clinical trial readiness.

BioEcho Life Sciences is a specialized biotechnology company providing innovative DNA and RNA extraction, isolation, and analysis solutions for pharmaceutical, academic, and industrial research. The company's proprietary EchoLUTION technology enables single-step nucleic acid purification that reduces processing time, plastic waste by up to 70%, and eliminates harsh chemical washing steps. BioEcho serves molecular diagnostics, biopharmaceutical research, biobanking, next-generation sequencing, and genomic analysis applications with ready-to-use kits, high-throughput automation solutions, and custom extraction services.